VIAD PHARMA ApS: Financial statements 2022
CVR: 36433892
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,006,597 and a net result of DKK 188,288 compared with DKK 250,426 the year before. That is a decrease of 4% compared with the year before. Equity in the 2022 report amounted to DKK 256,654. The solvency ratio was 11.2%.
- Gross Profit
- DKK 1,006,597
- Profit/Loss
- DKK 188,288
- Equity
- DKK 256,654
- Total Assets
- DKK 2,288,170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1 mio. | 188 t. | 257 t. | - |
| 2021 | - | 1 mio. | 250 t. | 319 t. | - |
| 2020 | - | 1.3 mio. | 458 t. | 526 t. | - |
| 2019 | - | 1.4 mio. | 555 t. | 668 t. | - |
| 2018 | - | 1.4 mio. | 553 t. | 714 t. | - |
Official annual report
Keep an eye on VIAD PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
VIAD PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,048,036, and the net result was DKK 250,426.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.